Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Clear all

335 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20023
20036
20045
20057
20065
20076
20087
200911
20109
20116
201213
20134
201413
201510
201613
201719
201814
201915
202016
202127
202215
202323
202421
202528
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed115
Recruiting74
Terminated69
Active, not recruiting25
Unknown status23
Withdrawn17
Not yet recruiting10
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
AstraZeneca6
Incyte Corporation5
M.D. Anderson Cancer Center5
Memorial Sloan Kettering Cancer Center5
Beijing Biotech4
Genmab4
Incyte Biosciences International Sàrl4
Roswell Park Cancer Institute4
ARCAGY/ GINECO GROUP3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms335
Breast Neoplasms80
Endometrial Neoplasms69
Carcinoma, Non-Small-Cell Lung62
Fallopian Tube Neoplasms59
Colorectal Neoplasms58
Pancreatic Neoplasms55
Stomach Neoplasms46
Uterine Cervical Neoplasms44
Carcinoma, Ovarian Epithelial43

Trials

Showing 76 to 100 of 335. Each trial links to its page on Pharma Observatory.

235 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.